Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply

被引：0
|
作者：
Hartl, Lukas [1 ,2 ,3 ]
Schwarz, Michael [1 ,2 ]
Simbrunner, Benedikt [1 ,2 ,3 ,4 ]
Jachs, Mathias [1 ,2 ,3 ]
Wolf, Peter [5 ]
Bauer, David Josef Maria [1 ,2 ]
Scheiner, Bernhard [1 ,2 ,3 ]
Balcar, Lorenz [1 ,2 ,3 ]
Semmler, Georg [1 ,2 ,3 ]
Hofer, Benedikt Silvester [1 ,2 ,3 ,4 ]
Dominik, Nina [1 ,2 ,3 ]
Marculescu, Rodrig [6 ]
Trauner, Michael [1 ,3 ]
Mandorfer, Mattias [1 ,2 ,3 ]
Reiberger, Thomas [1 ,2 ,3 ,4 ]
机构：
[1] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Clin Res Grp MOTION, Vienna, Austria
[4] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fib, Vienna, Austria
[5] Med Univ Vienna, Dept Med 3, Div Endocrinol, Vienna, Austria
[6] Med Univ Vienna, Dept Lab Med, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
关键词：
D O I：
10.1111/apt.18368
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [41] IGF-1 and IGFBP-3 in patients with liver disease
    Wallek, Grit
    Friedrich, Nele
    Ittermann, Till
    Mayerle, Julia
    Voelzke, Henry
    Nauck, Matthias
    Spielhagen, Christin
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (01): : 13 - 20
  • [42] Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis-authors' reply
    Forrest, Ewan
    Goldin, Robert
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (06) : 864 - 864
  • [43] Editorial: Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease-Authors' reply
    Gao, Feng
    Byrne, Christopher D.
    Targher, Giovanni
    Zhuo, Shuangmu
    Zheng, Ming-Hua
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (06) : 638 - 639
  • [44] IGF-1 and cardiovascular disease
    Higashi, Yusuke
    Gautam, Sandeep
    Delafontaine, Patrick
    Sukhanov, Sergiy
    GROWTH HORMONE & IGF RESEARCH, 2019, 45 : 6 - 16
  • [45] Authors' reply to letter on pharmacotherapy of chronic pain
    Kroenke, Kurt
    Krebs, Erin E.
    Bair, Matthew J.
    GENERAL HOSPITAL PSYCHIATRY, 2010, 32 (01) : 112 - 113
  • [46] Clinically Evident Portal Hypertension (CEPH) is Associated with Low IGF-1 in Children with Chronic Liver Disease
    Whitehead, B.
    Mohammad, S.
    Kelly, S.
    Josefson, J.
    Mithal, L.
    Alonso, E. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 794 - 795
  • [47] Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply
    Kuo, Selena Z.
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 297 - 298
  • [48] Letter: would aspirin alleviate fibrosis in alcoholic liver disease? Authors' reply
    Jiang, Z. G.
    Feldbrugge, L.
    Tapper, E. B.
    Popov, Y.
    Ghaziani, T.
    Afdhal, N.
    Robson, S. C.
    Mukamal, K. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (02) : 209 - 210
  • [49] Letter: antibiotic dose adjustment in patients with advanced liver disease - authors' reply
    Lewis, J. H.
    Stine, J. G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) : 562 - 562
  • [50] Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply
    Sasso, Roula
    Rockey, Don C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (01) : 91 - 91
12345